DNA gene chips or DNA microarrays are tiny chips that are engrafted with DNA molecules. A DNA gene chip size resembles the size of a postage stamp. A DNA microarray consists of a set of microscopic DNA spots attached on a solid surface. Every DNA spot consists of picomoles of a definite DNA sequence, known as probes. These probes can be a small section of a gene or a DNA element that are used to hybridize a cRNA or cDNA sample (called target) under stringent conditions. These powerful and versatile arrays are frequently used in genetic and medicinal research owing to their ability to speed up the research process. The primary research applications include comparative genomic hybridization, geneID, and profiling of gene expression as well as re-sequencing and genotyping in human, plant, eukaryotes, and prokaryotes genomes.
DNA gene chip technology is widely used in the drug discovery and medical research sector as it reduces the research time. The DNA gene chip enables medical researchers to measure the expression level of thousands of gene simultaneously. Large scale DNA/gene chip initiatives, growth of personalized medicines, and increase in the demand for early cancer detection and cancer diagnosis are factors likely to drive the global market growth for DNA gene chip during the forecast period. According to the World Health Organization, 8.2 million people died of cancer in 2012 globally. According to the American Cancer Society, about 300,000 men and 276,000 women died due to cancer in 2012 in the U.S.
The global DNA gene chip market has been segmented into DNA type, application, end-user, and geography. In terms of DNA type, the market is categorized into oligonucleotide DNA (oDNA) and complementary DNA (cDNA). Based on application, the market is segmented into gene expression, cancer diagnosis and treatment, DNA sequencing in hybridization, drug discovery, and others. In terms of end-user, the market is bifurcated into hospitals, contract research organizations, contract manufacturing organizations, pharmaceutical and biotechnology companies, and others.
In terms of geography, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest DNA gene chip market owing to favorable government policies and increase in incentives along with technological advancement in DNA gene chip. Europe is the second largest market for DNA gene chip due to growing prevalence of cancer, increasing government initiatives, and rising demand for early detection and diagnosis of cancer. According to the World Health Organization, with more than 3.7 million new cases and 1.9 million deaths each year, cancer represents the second leading cause of death and morbidity in Europe. Factors such as technological advancements, growth in infrastructure, and increase in the prevalence of cancer are projected to drive the Asia Pacific market growth. In addition, growing preference for clinical trials and drug discovery in countries such as China, Japan, and India is expected to propel the growth of the market in the region. Countries such as Brazil and Mexico are expected to support the expansion of the market in Latin American due to improving medical infrastructure, rising disposable income, and increasing establishment of manufacturing facilities by pharmaceutical and biotechnology companies.
Major players operating in the global DNA gene chip market include Thermo Fisher Scientific Inc., Agilent Technologies, bioMérieux SA, Biometrix Technology Inc., LifeGen Technologies LLC, Illumina, Inc., Merck KGaA, and PerkinElmer Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.